Literature DB >> 20112098

Asymmetrical cerebral perfusion demonstrated by noninvasive arterial spin-labeling perfusion imaging in a patient with corticobasal degeneration.

Tuvshinjargal Dashjamts1, Takashi Yoshiura, Akio Hiwatashi, Koji Yamashita, Koichiro Abe, Yasumasa Ohyagi, Junichi Kira, Hiroshi Honda.   

Abstract

This is to report arterial spin-labeling (ASL) regional cerebral blood flow (rCBF) mapping findings in a case of corticobasal degeneration (CBD). A 68-year-old man gradually developed limb-kinetic apraxia, myoclonus, and rigidity in the left hand and was diagnosed as having CBD. Magnetic resonance imaging and single photon emission computed tomography revealed atrophy and decreased blood flow, respectively, in the right hemisphere, findings that were compatible with CBD. In addition, ASL rCBF mapping demonstrated asymmetrical hypoperfusion areas in locations typical for CBD, proving its potential usefulness for routine clinical differential diagnosis.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20112098     DOI： 10.1007/s11604-009-0382-8

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN： 1867-1071            Impact factor:   2.374


  10 in total

1.  What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration.

Authors:  Murray Grossman; Corey McMillan; Peachie Moore; Lijun Ding; Guila Glosser; Melissa Work; James Gee
Journal:  Brain       Date:  2004-02-04       Impact factor: 13.501

2.  Model-free arterial spin labeling quantification approach for perfusion MRI.

Authors:  Esben Thade Petersen; Tchoyoson Lim; Xavier Golay
Journal:  Magn Reson Med       Date:  2006-02       Impact factor: 4.668

3.  Corticobasal degeneration: MR with histopathologic comparison.

Authors:  A M Tokumaru; T O'uchi; Y Kuru; T Maki; S Murayama; Y Horichi
Journal:  AJNR Am J Neuroradiol       Date:  1996 Nov-Dec       Impact factor: 3.825

4.  Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration.

Authors:  Keith A Josephs; David F Tang-Wai; Steven D Edland; David S Knopman; Dennis W Dickson; Joseph E Parisi; Ronald C Petersen; Clifford R Jack; Bradley F Boeve
Journal:  Arch Neurol       Date:  2004-12

5.  Atrophy of the corpus callosum, cortical hypometabolism, and cognitive impairment in corticobasal degeneration.

Authors:  H Yamauchi; H Fukuyama; Y Nagahama; Y Katsumi; Y Dong; T Hayashi; J Konishi; J Kimura
Journal:  Arch Neurol       Date:  1998-05

6.  Evaluation of cortical atrophy between progressive supranuclear palsy and corticobasal degeneration by hemispheric surface display of MR images.

Authors:  Masato Taki; Kazunari Ishii; Tetsuya Fukuda; Yoshio Kojima; Etsuro Mori
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

7.  Brain perfusion SPECT in patients with corticobasal degeneration: analysis using statistical parametric mapping.

Authors:  A K M Moinul Hossain; Yuji Murata; Lin Zhang; Shin-ichi Taura; Yukinobu Saitoh; Hidehiro Mizusawa; Kenji Oda; Eisuke Matsushima; Yoshiro Okubo; Hitoshi Shibuya
Journal:  Mov Disord       Date:  2003-06       Impact factor: 10.338

8.  Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy.

Authors:  B Okuda; H Tachibana; K Kawabata; M Takeda; M Sugita
Journal:  Alzheimer Dis Assoc Disord       Date:  2000 Jan-Mar       Impact factor: 2.703

9.  Signature tau neuropathology in gray and white matter of corticobasal degeneration.

Authors:  Mark S Forman; Victoria Zhukareva; Catherine Bergeron; Steven S-M Chin; Murray Grossman; Chris Clark; Virginia M-Y Lee; John Q Trojanowski
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

Review 10.  Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options.

Authors:  A C Ludolph; J Kassubek; B G Landwehrmeyer; E Mandelkow; E-M Mandelkow; D J Burn; D Caparros-Lefebvre; K A Frey; J G de Yebenes; T Gasser; P Heutink; G Höglinger; Z Jamrozik; K A Jellinger; A Kazantsev; H Kretzschmar; A E Lang; I Litvan; J J Lucas; P L McGeer; S Melquist; W Oertel; M Otto; D Paviour; T Reum; A Saint-Raymond; J C Steele; M Tolnay; H Tumani; J C van Swieten; M T Vanier; J-P Vonsattel; S Wagner; Z K Wszolek
Journal:  Eur J Neurol       Date:  2009-03       Impact factor: 6.089
  10 in total
  3 in total

1.  Arterial spin labeling imaging for the detection of cerebral blood flow asymmetry in patients with corticobasal syndrome.

Authors:  Tomohisa Yamaguchi; Masamichi Ikawa; Souichi Enomoto; Norimichi Shirafuji; Osamu Yamamura; Tetsuya Tsujikawa; Hidehiko Okazawa; Hirohiko Kimura; Yasunari Nakamoto; Tadanori Hamano
Journal:  Neuroradiology       Date:  2022-04-11       Impact factor: 2.995

Review 2.  Neuroimaging biomarkers of neurodegenerative diseases and dementia.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

3.  Intensity-Curvature Measurement Approaches for the Diagnosis of Magnetic Resonance Imaging Brain Tumors.

Authors:  Carlo Ciulla; Dimitar Veljanovski; Ustijana Rechkoska Shikoska; Filip A Risteski
Journal:  J Adv Res       Date:  2015-01-09       Impact factor: 10.479
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.